当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析

科源制药

(301281)

  

流通市值:20.41亿  总市值:32.11亿
流通股本:6885.20万   总股本:1.08亿

科源制药(301281)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.31亿元,每股收益0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益137144.73万元,未分配利润29986.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产160584.63万元,负债23439.90万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入302,688,076.14227,866,001.27111,204,722.41463,716,804.91
营业总成本278,777,760.56191,517,077.8493,014,492.94415,074,066.11
其他经营收益
营业利润28,023,489.3239,127,935.320,049,800.0468,262,611.87
利润总额31,944,668.743,765,022.7223,647,716.4665,708,514.67
净利润31,261,045.1742,641,961.623,067,656.4860,271,862.25
每股收益
其他综合收益----
综合收益总额31,261,045.1742,641,961.623,067,656.4860,271,862.25
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计633,272,572.62655,916,046.11680,167,116.36690,734,868.56
非流动资产:
非流动资产合计972,573,730.58948,429,558.82895,845,377.25861,739,402.58
资产总计1,605,846,303.21,604,345,604.931,576,012,493.611,552,474,271.14
流动负债:
流动负债合计112,547,307.04100,067,523.62102,712,817.61119,784,825.85
非流动负债:
非流动负债合计121,851,690.85122,175,539.5490,055,224.6673,085,908.6
负债合计234,398,997.89222,243,063.16192,768,042.27192,870,734.45
所有者权益(或股东权益):
归属于母公司股东权益合计1,370,849,035.031,381,335,721.41,382,453,759.441,358,795,634.77
股东权益合计1,371,447,305.311,382,102,541.771,383,244,451.341,359,603,536.69
负债和股东权益合计1,605,846,303.21,604,345,604.931,576,012,493.611,552,474,271.14
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计218,869,644.87151,884,597.7980,531,337.43367,204,068.33
经营活动现金流出小计191,629,723.54126,314,818.2881,083,486.09427,719,852.28
经营活动产生的现金流量净额27,239,921.3325,569,779.51-552,148.66-60,515,783.95
投资活动产生的现金流量:
投资活动现金流入小计513,337,958.8444,908,865.5179,091,865.86970,622,262.23
投资活动现金流出小计642,972,436.59383,244,915.81215,886,268.131,158,200,062.05
投资活动产生的现金流量净额-129,634,477.7961,663,949.69-36,794,402.27-187,577,799.82
筹资活动产生的现金流量:
筹资活动现金流入小计55,395,301.3853,617,376.0821,005,121.4347,631,955.6
筹资活动现金流出小计27,426,656.3525,142,879.525,558,296.732,562,968.66
筹资活动产生的现金流量净额27,968,645.0328,474,496.5615,446,824.7315,068,986.94
汇率变动对现金及现金等价物的影响488,714.31513,591.9415,142.81585,250.5
现金及现金等价物净增加额-73,937,197.12116,221,817.66-21,484,583.39-232,439,346.33
期末现金及现金等价物余额17,832,571.09207,991,585.8770,257,798.5291,769,768.21
补充资料:
现金及现金等价物的净增加额-116,221,817.66--232,439,346.33
TOP↑